Acumen Pharmaceuticals, Inc. (ABOS)
About Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$121.3M
- Total assets
- $122.8M
- Market cap
- $155.3M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $123.8M
- Operating income
- -$123.8M
- Income tax
- $0
- Net income
- -$121.3M
- EPS (basic)
- $-2.00
- EPS (diluted)
- $-2.00
Balance sheet
- Total assets
- $122.8M
- Current assets
- $122.3M
- Total liabilities
- $52.4M
- Current liabilities
- $30.0M
- Shareholders’ equity
- $70.4M
Cash flow
- Operating cash flow
- -$115.5M
- Investing cash flow
- $133.9M
- Financing cash flow
- -$34.0K
- Net cash flow
- $18.4M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $155.3M
- EPS (diluted)
- $-2.0
- Shares outstanding
- 72.9M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 1, 2021
Acumen Pharmaceuticals, Inc. (ABOS) Stock Price
- Reported a net loss of $121.3M.
- Trading 37% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Acumen Pharmaceuticals, Inc..
Write a review
News about Acumen Pharmaceuticals, Inc.
News & sentiment via Polygon.io
Acumen Pharmaceuticals, Inc.: frequently asked questions
Is Acumen Pharmaceuticals, Inc. an American company?
Acumen Pharmaceuticals, Inc. is a US-based company headquartered in Newton, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Acumen Pharmaceuticals, Inc. headquartered?
Acumen Pharmaceuticals, Inc. is headquartered in Newton, Massachusetts, United States.
Is Acumen Pharmaceuticals, Inc. publicly traded?
Yes — Acumen Pharmaceuticals, Inc. is a publicly traded company. Its stock trades under the ticker symbol ABOS on the NASDAQ.
What does Acumen Pharmaceuticals, Inc. do?
Acumen Pharmaceuticals, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
